Rezulin approval offers insulin-sparing hope for diabetics
FDA approves Parke Davis troglitazone to treat Type II diabetes, aiming to resensitize patients to insulin. In trials, 15 percent stopped insulin, 58 percent reduced daily doses. drug lowers glucose production and may prevent complications. Not for Type I diabetics. cautious use with doctor guidance urged.
MENTIONED IN THIS ARTICLE
FDA
Washington
Food and Drug Administration
Parke Davis
Philip Cryer
American Diabetes Association
Parke
Davis
Solomon Sobel
National Institutes of Health
Polio Vaccine Policy Shifts After Vaccine Induced Cases
The CDC reports 133 polio cases in 1980 1994 and 125 were vaccine induced by the oral polio vaccine. A new regimen begins this month using an injected killed virus followed by oral doses to reduce risk. The policy aims to curb vaccine derived polio with a first injection regime and then oral vaccination.
MENTIONED IN THIS ARTICLE
Atlanta
United States
Rebecca Prevots
Centers For Disease Control and Prevention
CDC
Light Cigarettes Misleading Tar and Nicotine Levels Reported
A Massachusetts study finds lighter labeled cigarettes deliver higher tar and nicotine than labeled, with Marlboro Lights and Camel Lights showing wider ranges. Experts compare this to skim milk sold as whole cream, warning consumers about misrepresented contents and health risks. A separate Atlanta report notes a flu strain surge may be peaking, with nationwide spread slowing but Death tolls still under study as CDC tracks weekly mortality rates.
MENTIONED IN THIS ARTICLE
Boston
Massachusetts
Jack B. Heningfield
John Hopkins Medical School
Atlanta
Centers For Disease Control and Prevention
Nancy Arden
CDC
Wuhan
Ms Arden
Also Mentioned on This Page
Adl
Ae Last
Broyhill
La-Z-Boy
Klaussner
Sealy
Kingsdown
Kincaid
Pulaski
Wesley Hall
Vaughan
Lexington
Bob Timberlake
Balin
Chris & Loft
Sing Hotere Ndery
eBroyhal
Calle
Frederick
East Street
Sun